{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:56:02Z","timestamp":1759056962033},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Graduate Student Scientific Research Innovation Project of Chongqing","award":["CYB15096"],"award-info":[{"award-number":["CYB15096"]}]},{"name":"Excellent Doctoral Dissertation Scientific Research Funding of Chongqing Medical University","award":["41021300160151"],"award-info":[{"award-number":["41021300160151"]}]},{"name":"Social Programs and People's Livelihood Guarantee Technology Innovation Special Project of Chongqing","award":["cstc2016shmszx1319"],"award-info":[{"award-number":["cstc2016shmszx1319"]}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.biopha.2017.04.025","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T10:32:55Z","timestamp":1492684375000},"page":"821-834","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Activation of imidazoline I1 receptor by moxonidine regulates the progression of liver fibrosis in the Nrf2-dependent pathway"],"prefix":"10.1016","volume":"90","author":[{"given":"Wenfeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9930","key":"10.1016\/j.biopha.2017.04.025_bib0005","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/S0140-6736(14)60815-1","article-title":"Management of liver cirrhosis","volume":"383","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.biopha.2017.04.025_bib0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jhep.2014.03.006","article-title":"Improving performance of liver biopsy in fibrosis assessment","volume":"61","author":"Asselah","year":"2014","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2017.04.025_bib0015","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/hep.27868","article-title":"Erythropoietin-producing hepatocellular receptor B2 receptor tyrosine kinase: a novel regulator of infection- and inflammation-induced liver fibrosis","volume":"62","author":"Butler","year":"2015","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.biopha.2017.04.025_bib0020","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.ajpath.2016.06.003","article-title":"Pathogenesis of kupffer cells in cholestatic liver injury","volume":"186","author":"Sato","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.biopha.2017.04.025_bib0025","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jhep.2015.07.020","article-title":"Exposure to fine airborne particulate matters induces hepatic fibrosis in murine models","volume":"63","author":"Zheng","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2017.04.025_bib0030","article-title":"Loss of the TGF-beta effector beta2SP promotes genomic instability","author":"Chen","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2017.04.025_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2013.01.008","article-title":"Innate immunity","volume":"25","author":"Hoffmann","year":"2013","journal-title":"Curr. Opin. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2017.04.025_bib0040","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1053\/j.gastro.2004.08.028","article-title":"From quiescence to activation: gene regulation in hepatic stellate cells","volume":"127","author":"Rippe","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.biopha.2017.04.025_bib0045","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15027419","article-title":"Expression of toll-like receptors in hepatic cirrhosis and hepatocellular carcinoma","volume":"15","author":"Sun","year":"2016","journal-title":"Genet. Mol. Res.: GMR"},{"key":"10.1016\/j.biopha.2017.04.025_bib0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2016.10.005","article-title":"Early innate immune responses to bacterial LPS","volume":"44","author":"Rosadini","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biopha.2017.04.025_bib0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.abb.2014.02.015","article-title":"Cellular and molecular mechanisms in liver fibrogenesis","volume":"548","author":"Novo","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"issue":"15","key":"10.1016\/j.biopha.2017.04.025_bib0060","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/1873-3468.12301","article-title":"p62\/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer","volume":"590","author":"Taniguchi","year":"2016","journal-title":"FEBS Lett."},{"issue":"10","key":"10.1016\/j.biopha.2017.04.025_bib0065","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/labinvest.2008.75","article-title":"The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis","volume":"88","author":"Xu","year":"2008","journal-title":"Lab. Invest.; J. Tech. Methods Pathol."},{"key":"10.1016\/j.biopha.2017.04.025_bib0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tox.2016.07.018","article-title":"Nrf2 knockdown attenuates the ameliorative effects of ligustrazine on hepatic fibrosis by targeting hepatic stellate cell transdifferentiation","volume":"365","author":"Lu","year":"2016","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.biopha.2017.04.025_bib0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1152\/japplphysiol.00721.2015","article-title":"Sulforaphane mitigates muscle fibrosis in mdx mice via Nrf2-mediated inhibition of TGF-beta\/Smad signaling","volume":"120","author":"Sun","year":"2016","journal-title":"J. Appl. Physiol."},{"issue":"11","key":"10.1016\/j.biopha.2017.04.025_bib0080","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.cellsig.2014.07.016","article-title":"MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis","volume":"26","author":"Yang","year":"2014","journal-title":"Cell. Signal."},{"issue":"5","key":"10.1016\/j.biopha.2017.04.025_bib0085","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3109\/15563650.2014.898770","article-title":"Significance of the imidazoline receptors in toxicology","volume":"52","author":"Lowry","year":"2014","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.biopha.2017.04.025_bib0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.brainres.2008.11.008","article-title":"Interruption of central neuronal pathway of imidazoline I1 receptor mediates the hypertensive effect of cyclosporine in rats","volume":"1248","author":"El-Mas","year":"2009","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.biopha.2017.04.025_bib0095","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1055\/s-0033-1334946","article-title":"Improvement of obesity by activation of I1-imidazoline receptors in high fat diet-fed mice","volume":"45","author":"Chung","year":"2013","journal-title":"Hormone and metabolic research=Hormon- und Stoffwechselforschung=Hormones et metabolisme"},{"key":"10.1016\/j.biopha.2017.04.025_bib0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainresbull.2014.02.007","article-title":"Pharmacological benefit of I(1)-imidazoline receptors activation and nuclear factor kappa-B (NF-kappaB) modulation in experimental Huntington's disease","volume":"102","author":"Gupta","year":"2014","journal-title":"Brain Res. Bull."},{"issue":"February (1)","key":"10.1016\/j.biopha.2017.04.025_bib0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10787-016-0299-7","article-title":"Analysing the effect of I1 imidazoline receptor ligands on DSS-induced acute colitis in mice","volume":"25","author":"Feher","year":"2017","journal-title":"Inflammopharmacology"},{"issue":"2","key":"10.1016\/j.biopha.2017.04.025_bib0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/luts.12031","article-title":"Urinary bladder relaxation through activation of imidazoline receptors induced by agmatine is increased in diabetic rats","volume":"6","author":"Tsai","year":"2014","journal-title":"Lower Urinary Tract Symptoms"},{"issue":"4","key":"10.1016\/j.biopha.2017.04.025_bib0115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/00003495-200666040-00006","article-title":"Moxonidine: a review of its use in essential hypertension","volume":"66","author":"Fenton","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2017.04.025_bib0120","doi-asserted-by":"crossref","first-page":"541689","DOI":"10.1155\/2013\/541689","article-title":"Improved hypertension control with the imidazoline agonist moxonidine in a multinational metabolic syndrome population: principal results of the MERSY study","volume":"2013","author":"Chazova","year":"2013","journal-title":"Int. J. Hypertens."},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2017.04.025_bib0125","article-title":"Br 04-1management of treatment-Resistant hypertension","volume":"34","author":"Webb","year":"2016","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.biopha.2017.04.025_bib0130","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1476-5381.2011.01355.x","article-title":"Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and Akt","volume":"164","author":"Aceros","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2017.04.025_bib0135","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1097\/HJH.0b013e328364a2a1","article-title":"Moxonidine-induced central sympathoinhibition improves prognosis in rats with hypertensive heart failure","volume":"31","author":"Honda","year":"2013","journal-title":"J. Hypertens."},{"issue":"2","key":"10.1016\/j.biopha.2017.04.025_bib0140","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.biopha.2017.04.025_bib0145","doi-asserted-by":"crossref","first-page":"e0136774","DOI":"10.1371\/journal.pone.0136774","article-title":"Mouse CD11b+Kupffer cells recruited from bone marrow accelerate liver regeneration after partial hepatectomy","volume":"10","author":"Nishiyama","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2017.04.025_bib0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.gene.2016.03.008","article-title":"Study of pathway cross-talk interactions with NF-kappaB leading to its activation via ubiquitination or phosphorylation: a brief review","volume":"584","author":"Ghosh","year":"2016","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.biopha.2017.04.025_bib0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2174\/1871530315666150316120112","article-title":"One special question to start with: can HIF\/NFkB be a target in inflammation?","volume":"15","author":"Russo","year":"2015","journal-title":"Endocrine Metab. Immune Disord. Drug Targets"},{"issue":"24","key":"10.1016\/j.biopha.2017.04.025_bib0160","doi-asserted-by":"crossref","first-page":"E3451","DOI":"10.1073\/pnas.1506113113","article-title":"Thyroid hormones inhibit TGF-beta signaling and attenuate fibrotic responses","volume":"113","author":"Alonso-Merino","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.biopha.2017.04.025_bib0165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1369\/0022155415627681","article-title":"TGF-beta\/SMAD pathway and its regulation in hepatic fibrosis","volume":"64","author":"Xu","year":"2016","journal-title":"J. Histochem. Cytochem."},{"issue":"Pt A","key":"10.1016\/j.biopha.2017.04.025_bib0170","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jep.2014.10.028","article-title":"Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-beta\/Smad interference","volume":"158","author":"Jiang","year":"2014","journal-title":"J. Ethnopharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2017.04.025_bib0175","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00018-014-1798-6","article-title":"EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-beta\/Smad and ROS signaling","volume":"72","author":"Park","year":"2015","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"issue":"2","key":"10.1016\/j.biopha.2017.04.025_bib0180","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3390\/cells4020169","article-title":"What is known regarding the participation of factor nrf-2 in liver regeneration?","volume":"4","author":"Morales-Gonzalez","year":"2015","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.biopha.2017.04.025_bib0185","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","article-title":"Nrf2 signaling pathway: pivotal roles in inflammation","volume":"1863","author":"Ahmed","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2017.04.025_bib0190","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.redox.2016.11.013","article-title":"Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis","volume":"11","author":"Duarte","year":"2016","journal-title":"Redox Biol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217303797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217303797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T23:17:31Z","timestamp":1719875851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217303797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":38,"alternative-id":["S0753332217303797"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.04.025","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of imidazoline I1 receptor by moxonidine regulates the progression of liver fibrosis in the Nrf2-dependent pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}